Literature DB >> 7811026

Effect of enteral feeding with ensure on oral bioavailabilities of ofloxacin and ciprofloxacin.

B A Mueller1, D G Brierton, S R Abel, L Bowman.   

Abstract

The relative oral bioavailabilities of ciprofloxacin and ofloxacin when they were coadministered with water or an enteral feeding product (Ensure) were assessed in 13 healthy volunteers. The area under the concentration time curve from time zero to infinity and the maximum concentration of drug in serum for both drugs were reduced by Ensure in comparison with those by water (P < 0.01). However, Ensure reduced the percent relative bioavailability of ciprofloxacin (72% +/- 14%; range, 52 to 96%) significantly more than ofloxacin (90% +/- 8.3%; range, 74 to 105%) (P < 0.005). Coadministration of Ensure significantly diminished ciprofloxacin and ofloxacin absorption, but ciprofloxacin absorption was reduced significantly more than ofloxacin absorption.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7811026      PMCID: PMC284691          DOI: 10.1128/AAC.38.9.2101

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  41 in total

1.  Effects of two cations on gastrointestinal absorption of ofloxacin.

Authors:  M Martínez Cabarga; A Sánchez Navarro; C I Colino Gandarillas; A Domínguez-Gil
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

2.  Effect of staggered dose of calcium on the bioavailability of ciprofloxacin.

Authors:  B M Lomaestro; G R Bailie
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

3.  Interference of dairy products with the absorption of ciprofloxacin.

Authors:  P J Neuvonen; K T Kivistö; P Lehto
Journal:  Clin Pharmacol Ther       Date:  1991-11       Impact factor: 6.875

4.  Effect of food on absorption of lomefloxacin.

Authors:  W D Hooper; R G Dickinson; M J Eadie
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

5.  Relative bioavailability in healthy volunteers of ciprofloxacin administered through a nasogastric tube with and without enteral feeding.

Authors:  J H Yuk; C H Nightingale; K R Sweeney; R Quintiliani; J T Lettieri; R W Frost
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

6.  Clinical and chemical interactions between iron preparations and ciprofloxacin.

Authors:  M Kara; B B Hasinoff; D W McKay; N R Campbell
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

7.  Effects of magnesium-aluminum hydroxide and calcium carbonate antacids on bioavailability of ofloxacin.

Authors:  S Flor; D R Guay; J A Opsahl; K Tack; G R Matzke
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

8.  Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics.

Authors:  J A Paladino; H E Sperry; J M Backes; J A Gelber; D J Serrianne; T J Cumbo; J J Schentag
Journal:  Am J Med       Date:  1991-11       Impact factor: 4.965

9.  Clinical and economic impact of oral ciprofloxacin as follow-up to parenteral antibiotics.

Authors:  T H Grasela; J A Paladino; J J Schentag; D Huepenbecker; J Rybacki; J B Purcell; J B Fiedler
Journal:  DICP       Date:  1991 Jul-Aug

10.  Combined use of ciprofloxacin and sucralfate.

Authors:  A D Van Slooten; D E Nix; J H Wilton; J H Love; J M Spivey; H R Goldstein
Journal:  DICP       Date:  1991-06
View more
  18 in total

1.  Effects of dairy products on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in healthy volunteers.

Authors:  H Stass; D Kubitza
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 2.  Food-drug interactions.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 3.  Pharmacokinetic and pharmacodynamic issues in the treatment of bacterial infectious diseases.

Authors:  P S McKinnon; S L Davis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-10       Impact factor: 3.267

Review 4.  Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials.

Authors:  A Aminimanizani; P Beringer; R Jelliffe
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

5.  The bioavailability of bromazepam, omeprazole and paracetamol given by nasogastric feeding tube.

Authors:  Gregory Podilsky; Markoulina Berger-Gryllaki; Bernard Testa; Thierry Buclin; Michel Roulet; Andre Pannatier
Journal:  Eur J Clin Pharmacol       Date:  2009-02-03       Impact factor: 2.953

6.  Clinical Equivalency of Ciprofloxacin 750 mg Enterally and 400 mg Intravenously for Patients Receiving Enteral Feeding: Systematic Review.

Authors:  Donna Chui; Lily Cheng; Aaron M Tejani
Journal:  Can J Hosp Pharm       Date:  2009-03

Review 7.  Clinically significant interactions with drugs used in the treatment of tuberculosis.

Authors:  W W Yew
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

8.  Bioavailability of ciprofloxacin after multiple enteral and intravenous doses in ICU patients with severe gram-negative intra-abdominal infections.

Authors:  S de Marie; M F VandenBergh; S L Buijk; H A Bruining; A van Vliet; J A Kluytmans; J W Mouton
Journal:  Intensive Care Med       Date:  1998-04       Impact factor: 17.440

Review 9.  Antibiotic dosing in critically ill patients with acute kidney injury.

Authors:  Rachel F Eyler; Bruce A Mueller
Journal:  Nat Rev Nephrol       Date:  2011-02-22       Impact factor: 28.314

Review 10.  Ofloxacin. A reappraisal of its use in the management of genitourinary tract infections.

Authors:  S V Onrust; H M Lamb; J A Balfour
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.